Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Screening for fracture risk is mandatory in renal transplant patients on even low-dose maintenance steroids

Nature Clinical Practice Nephrology volume 3, pages 314–315 (2007)Cite this article

boxed-textFarmer CK et al. (2006) Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am J Transplant 6: 2929–2936

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. van Staa TP et al. (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39: 1383–1389

    Article  CAS  Google Scholar 

  2. ter Meulen CG et al. (2004) No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study. Transplantation 78: 101–106

    Article  Google Scholar 

  3. Westenfeld R et al. (2006) Bisphosphonates can improve bone mineral density in renal transplant recipients. Nat Clin Pract Nephrol 2: 676–677

    Article  Google Scholar 

  4. Boots JM et al. (2001) Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients. Transpl Int 14: 370–383

    Article  CAS  Google Scholar 

  5. Pascual J et al. (2006) Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Transplantation 82: 55–61

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. JP van Hooff is an Internist and Nephrologist, P Geusens is a Rheumatologist, and MHL Christiaans is an Internist and Nephrologist, at the University Hospital Maastricht, Maastricht, The Netherlands.,

    Johannes P van Hooff, Piet Geusens & Maarten HL Christiaans

Authors
  1. Johannes P van Hooff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Piet Geusens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maarten HL Christiaans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes P van Hooff.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Hooff, J., Geusens, P. & Christiaans, M. Screening for fracture risk is mandatory in renal transplant patients on even low-dose maintenance steroids. Nat Rev Nephrol 3, 314–315 (2007). https://doi.org/10.1038/ncpneph0487

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0487

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing